After the Human Research Ethics Committee (HREC) rejected the Company’s flagship drug, EmtinB, knocking back years of research in the process, disappointed CEO and Managing Director, Mr Matt Liddelow, announced that he is resigning from his position immediately. Liddelow noted, “I acknowledge the loss in shareholder value as a result of the rejected Human Research
Read More
What do you do when you lose nearly $100 million in only six months? Re-evaluate everything. That’s exactly what defence, space and communications company Electro Optic Systems (ASX: EOS) is doing as it expresses disappointment in its first half result, losing $98.9 million in six months ending June 30, 2022. The loss is even more
Read More
Conventional property settlement is daunting for some of us. Having to go back and forth to lawyers, conveyancers, and financial institution offices during lunch breaks is rather time consuming and stressful. As the world progresses to the digital era, PEXA (ASX: PXA) has been facilitating 80% of modern property exchanges in Australia by creating a
Read More
Obsessive fantasy sports team coach Vic Vinegar has almost taken home the biggest win of the season, as office people-pleaser Hugh Honey finally relents, saying ‘sounds fun, I’ll give it a go’ to Vinegar’s long winded explanation of his fantasy NFL draft. As the NFL season kicks off, Vinegar has been on the prowl to
Read More
The board of digital payments company Tyro Payments (ASX: TYR) has politely rejected a $658 million takeover bid from Potentia Capital Management and its consortium, where the unsolicited offer values the Group at $1.27 per share, a 30% premium above yesterday’s close price of $0.985. The tech-focussed consortium comprises HarbourVest Partners, MLC Investments and the
Read More
Before there was Covid-19, viruses like Zika were baffling the medical community and the world, of course. Today, the Zika virus market is worth approximately US$17 billion; yet, it has no treatment. Hopefully, that may not be the case for long as life-sciences company Invion (ASX: IVX) has announced that its patented tech PhotosoftTM has
Read More